幕后AI巨头：Exscientia与住友制药

DSP-1181是英国AI药物公司Exscientia与日本住友制药（Sumitomo Dainippon Pharma）合作的成果。Exscientia利用其Centaur Chemist™ AI平台，结合住友制药在单胺GPCR药物发现领域的经验，实现了此次突破。

来源

• Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Study
• Sumitomo Dainippon Pharma, Exscientia advance AI drug candidate
• Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins
• Big Pharma Increases Partnerships with AI Vendors for Drug Discovery
• Exscientia Announces Second Molecule Created Using AI From Sumitomo Dainippon Pharma Collaboration to Enter Phase 1 Clinical Trial - Business Wire
• 全球首个由AI设计进入临床的药物已停止研发 - 智源社区

打开完整版